Scientists from the Institute of Cancer Research (ICR) have found a new method for predicting bowel cancer risk in ...

Amgen’s Blincyto (blinatumomab) has been approved by the European Commission (EC) to treat certain acute lymphoblastic ...

The National Institute for Health and Care Excellence (NICE) has approved Vertex Pharmaceuticals’ Casgevy (exagamglogene ...

With a menu featuring everything from cutting-edge science to DEI and diet, ASH 2024 certainly offered congress attendees ...

Novo Nordisk’s Ozempic (semaglutide) has been approved by the US Food and Drug Administration (FDA) to reduce the risk of ...

In trials at University College London Hospitals (UCLH), an ASO is being used to target the mutated gene that results in the ...

Levi Garraway, Roche’s chief medical officer and head of global product development, said: “The INAVO120 overall survival ...

Havas Health Network has launched Havas Life London, an evolution of Havas Life Medicom that is “deeply rooted” in the agency ...

Bayer Consumer Health has launched a digital educational resource to support perimenopausal or menopausal patients in the UK.

AstraZeneca (AZ) has received two separate recommendations from the National Institute for Health and Care Excellence (NICE) ...

AstraZeneca (AZ) and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved by the US Food and Drug ...

A new European survey sponsored by AstraZeneca (AZ) and Daiichi Sankyo has revealed widespread misconceptions about breast ...